Borrego-Diaz Emma, Powers Benjamin C, Azizov Vugar, Lovell Scott, Reyes Ruben, Chapman Bradley, Tawfik Ossama, McGregor Douglas, Diaz Francisco J, Wang Xinkun, Veldhuizen Peter Van
Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA.
Protein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Main Campus, Lawrence, KS 66047, USA.
Int J Oncol. 2014 Dec;45(6):2421-9. doi: 10.3892/ijo.2014.2647. Epub 2014 Sep 9.
Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regul-ates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains.
Lin28是一类RNA结合蛋白和微小RNA调节因子。该家族已鉴定出两个成员:Lin28A和Lin28B,它们由位于不同染色体上的基因编码,但具有高度的序列同一性。Lin28B在雄激素非依赖性前列腺癌(AIPC)中的作用尚不清楚。Lin28B在所有级别的前列腺癌和前列腺癌细胞系中均有表达,但在正常前列腺组织中不表达。在本研究中,我们发现Lin28B在DU145 AIPC的细胞核和细胞质中均有共定位。Lin28B蛋白的表达与前列腺癌细胞系中c-Myc蛋白的表达呈正相关,并且Lin28B的沉默也与DU145 AIPC细胞中c-Myc蛋白的低表达相关,但与c-Myc信使核糖核酸(mRNA)的下调无关。我们推测Lin28B通过改变中间的c-Myc抑制因子来调节c-Myc蛋白的表达。因此,在Lin28B小干扰RNA(siRNA)沉默后,对DU145细胞进行了微小RNA谱分析。19种微小RNA上调,11种微小RNA下调。上调最明显的微小RNA是miR-212和miR-2278。先前的报道发现miR-212在前列腺癌中受到抑制。然后我们运行TargetScan软件来寻找miR-212和miR-2278的潜在靶mRNA,它预测Lin28B mRNA是miR-212的潜在靶标,但不是miR-2278的。TargetScan还预测c-Myc mRNA不是miR-212或miR-2278的潜在靶标。这些观察结果表明,Lin28B:miR-212可能在雄激素非依赖性前列腺癌中作为一个调节环发挥作用。此外,我们报告了一个通过将Lin28A结构叠加到Lin28B的I-TASSER模型上生成的预测性2倍对称模型。Lin28B的这种结构模型表明它具有独特的微小RNA结合特性。因此,如果Lin28B以类似于Lin28A的方式结合微小RNA,那么在CSD和ZNF结构域之间的C末端和连接区就需要构象变化来防止空间冲突。